Advertisement

Management of Female Stress Urinary Incontinence

  • Giampiero CapobiancoEmail author
  • Pier Luigi Cherchi
  • Salvatore Dessole
Chapter

Abstract

Stress urinary incontinence (SUI) is a condition characterized by an involuntary loss of urine occurring as result of an increase of intra-abdominal pressure due to effort or exertion or on sneezing or coughing. It is estimated to have a prevalence between 10 and 40% of the female population. Surgical therapy should be indicated only after conservative therapies (rehabilitation, local oestrogenic) have failed. The synthetic midurethral slings are the gold standard for the surgical treatment of the SUI according to the guidelines 2016 of the European Society of Urology and the position statement of the 2017 of the European Urogynaecological Association. When offering a surgical procedure, the specialist should discuss with the woman the risks and benefits of the different treatment options for SUI. Patients should have the opportunity to make informed decisions about their care and treatment, in partnership with their healthcare professionals. The therapeutic options available today are numerous, but the current trend is aimed at the continuous research of new therapeutic strategies in order to achieve an ever better balance between high efficacy and maximum reduction of adverse events.

Keywords

Stress urinary incontinence (SUI) Management Midurethral sling Tension-free vaginal tape (TVT) Transobturator tape (TOT, TVT-O) Urethral bulking agents (UBAs) 

Notes

Conflict of Interest Disclosure

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

  1. 1.
    Tantanasis T, Daniilidis A, Pantelis A, Chatzis P, Vrachnis N. Minimally invasive techniques for female stress urinary incontinence, how, why, when. Arch Gynecol Obstet. 2013;288(5):995–1001.PubMedCrossRefGoogle Scholar
  2. 2.
    Hunskaar S, Burgio K, Diokno A, Herzog AR, Hjälmås K, Lapitan MC. Epidemiology and natural history of urinary incontinence in women. Urology. 2003;62(4Suppl 1):16–23.PubMedCrossRefGoogle Scholar
  3. 3.
    Patel DA, Xu X, Thomason AD, Ransom SB, Ivy JS, DeLancey JO. Childbirth and pelvic floor dysfunction: an epidemiologic approach to the assessment of prevention opportunities at delivery. Am J Obstet Gynecol. 2006;195(1):23–8.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Alas AN, Chinthakanan O, Espaillat L, Plowright L, Davila GW, Aguilar VC. De novo stress urinary incontinence after pelvic organ prolapse surgery in women without occult incontinence. Int Urogynecol J. 2017;28(4):583–90.PubMedCrossRefGoogle Scholar
  5. 5.
    Urinary Incontinence in Women. The management of urinary incontinence in women: NICE clinical guideline CG171. London: National Institute for Health and Care Excellence; 2013. http://guidance.nice.org.uk/CG171
  6. 6.
    Thüroff JW, Abrams P, Andersson KE, et al. European Association of Urology. EAU guidelines on urinary incontinence. Actas Urol Esp. 2011;35(7):373–88.PubMedCrossRefGoogle Scholar
  7. 7.
    Capobianco G, Wenger JM, Meloni GB, Dessole M, Cherchi PL, Dessole S. Triple therapy with lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women. Arch Gynecol Obstet. 2014;289(3):601–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Maund E, Schow Guski L, Gotzsche PC. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. CMAJ. 2017;189:E194–203.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017;99:10–5.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Baraldi CE, Puricelli E, Kulkes S, Martins GL. Er YAG laser in oral soft tissue surgery. JOLA. 2001;59:17–20.Google Scholar
  11. 11.
    Fistonić N, Fistonić I, Guštek ŠF, et al. Minimally invasive, non-ablative Er: YAG laser treatment of stress urinary incontinence in women--a pilot study. Lasers Med Sci. 2016;31(4):635–43.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric. 2015;18(5):757–63.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol. 1981;141(7):817–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Matsubara S, Okada H, Shirakawa T, Gotoh A, Kuno T, Kamidono S. Estrogen levels influence beta-3-adrenoceptor-mediated relaxation of the female rat detrusor muscle. Urology. 2002;59(4):621–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol. 1994;83(1):12–8.PubMedGoogle Scholar
  16. 16.
    Dessole S, Rubattu G, Ambrosini G, et al. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause. 2004;11(1):49–56.PubMedCrossRefGoogle Scholar
  17. 17.
    Capobianco G, Donolo E, Borghero G, Dessole F, Cherchi PL, Dessole S. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet. 2012;285(2):397–403.PubMedCrossRefGoogle Scholar
  18. 18.
    Committee Opinion No. 603. Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Obstet Gynecol. 2014;123(6):1403–7.CrossRefGoogle Scholar
  19. 19.
    Stoppelli I, Milia S, Dessole S, Geromino A. Further considerations on colpo-suspension by Burch’s method in the correction of stress urinary incontinence. Minerva Ginecol. 1983;35(6):417–21.PubMedGoogle Scholar
  20. 20.
    Capobianco G, Madonia M, Morelli S, Dessole F, De Vita D, Cherchi PL, Dessole S. Management of female stress urinary incontinence: a care pathway and update. Maturitas. 2018;109:32–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Capobianco G, Morelli S, Dessole F, Cherchi PL, Dessole S, Madonia M, De Vita D. Reply to Dr Wael Agur. Maturitas. 2018;110:125.PubMedCrossRefGoogle Scholar
  22. 22.
    Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2009;(4):CD006375.Google Scholar
  23. 23.
    Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol. 2010;58(2):218–38.PubMedCrossRefGoogle Scholar
  24. 24.
    Ulmsten U, Petros P. Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scand J Urol Nephrol. 1995;29(1):75–82.PubMedCrossRefGoogle Scholar
  25. 25.
    Ulmsten U, Falconer C, Johnson P, et al. A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(4):210–3.PubMedCrossRefGoogle Scholar
  26. 26.
    Kristensen I, Eldoma M, Williamson T, Wood S, Mainprize T, Ross S. Complications of the tension-free vaginal tape procedure for stress urinary incontinence. Int Urogynecol J. 2010;21(11):1353–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Kim HG, Park HK, Paick SH, Choi WS. Comparison of effectiveness between tension-free vaginal tape (TVT) and trans-obturator tape (TOT) in patients with stress urinary incontinence and intrinsic sphincter deficiency. PLoS One. 2016;11(5):e0156306.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Long CY, Hsu CS, Wu MP, Liu CM, Wang TN, Tsai EM. Comparison of tension-free vaginal tape and transobturator tape procedure for the treatment of stress urinary incontinence. Curr Opin Obstet Gynecol. 2009;21(4):342–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Ford AA, Rogerson L, Cody JD, Aluko P, Ogah J. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017;(7):CD006375.Google Scholar
  30. 30.
    Kurien A, Narang S, Han HC. Tension-free vaginal tape-Abbrevo procedure for female stress urinary incontinence: a prospective analysis over 22 months. Singap Med J. 2017;58(6):338–42.CrossRefGoogle Scholar
  31. 31.
    Capobianco G, Dessole M, Lutzoni R, Surico D, Ambrosini G, Dessole S. TVT-ABBREVO: efficacy and two years follow-up for the treatment of stress urinary incontinence. Clin Exp Obstet Gynecol. 2014;41(4):445–7.PubMedGoogle Scholar
  32. 32.
    Leone Roberti Maggiore U, Finazzi Agrò E, Soligo M, Li Marzi V, Digesu A, Serati M. Long-term outcomes of TOT and TVT procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2017;28(8):1119–30.PubMedCrossRefGoogle Scholar
  33. 33.
    Tommaselli GA, Di Carlo C, Formisano C, Fabozzi A, Nappi C. Medium-term and long-term outcomes following placement of midurethral slings for stress urinary incontinence: a systematic review and metaanalysis. Int Urogynecol J. 2015;26(9):1253–68.PubMedCrossRefGoogle Scholar
  34. 34.
    Frigerio M, Regini C, Manodoro S, Spelzini F, Milani R. Mini-sling efficacy in obese versus non-obese patients for treatment of stress urinary incontinence. Minerva Ginecol. 2017;69(6):533–7.Google Scholar
  35. 35.
    American Urological Association. Incontinence 2017. https://www.auanet.org/education/guidelines/incontinence.cfm.
  36. 36.
    Mamut A, Carlson KV. Periurethral bulking agents for female stress urinary incontinence in Canada. Can Urol Assoc J. 2017;11(6 Suppl 2):S152–4.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Herschorn S. Injection therapy for urinary incontinence. In: Wein A, Kavoussi LR, Novick AC, et al., editors. Campbell-Walsh urology. 11th ed. Philadelphia: Saunders; 2013. p. 2049–69.Google Scholar
  38. 38.
    Kotb AF, Campeau L, Corcos J. Urethral bulking agents: techniques and outcomes. Curr Urol Rep. 2009;10:396–400.PubMedCrossRefGoogle Scholar
  39. 39.
    American Urological Association. Incontinence 2016. Linthicum: American Urological Association; 2017. https://www.auanet.org/education/guidelines/incontinence.cfm. Accessed 30 Jan 2017.Google Scholar
  40. 40.
    National Institute for Health and Care Excellence. Intramural urethral bulking procedures for stress urinary incontinence in women. London: National Institute for Health and Care Excellence; 2005. https://www.nice.org.uk/guidance/IPG138/chapter/2-Theprocedure. Accessed 30 Jan 2017.Google Scholar
  41. 41.
    Kasi AD, Pergialiotis V, Perrea DN, Khunda A, Doumouchtsis SK. Polyacrylamide hydrogel (Bulkamid®) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J. 2016;27(3):367–75.PubMedCrossRefGoogle Scholar
  42. 42.
    Siddiqui ZA, Abboudi H, Crawford R, Shah S. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review. Int Urogynecol J. 2017;28(9):1275–84.PubMedCrossRefGoogle Scholar
  43. 43.
    Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results. J Urol. 2010;183(4):1444–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Ghoniem GM, Miller CJ. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J. 2013;24(1):27–36.PubMedCrossRefGoogle Scholar
  45. 45.
    Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2012;(2):CD003881.Google Scholar
  46. 46.
    de Vries AM, van Breda HM, Fernandes JG, Venema PL, Heesakkers JP. Para-urethral injections with Urolastic® for treatment of female stress urinary incontinence: subjective improvement and safety. Urol Int. 2017;99(1):91–7.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Capobianco G, Azzena A, Saderi L, Dessole F, Dessole S, Sotgiu G. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2018:29(9):1239–47.PubMedCrossRefGoogle Scholar
  48. 48.
    Smith AR, Dmochowski R, Hilton P, et al. Committee 14: surgery for urinary incontinence in women. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 4th ed. Paris: Health Publication; 2009. p. 1191–272.Google Scholar
  49. 49.
    Jonsson Funk M, Siddiqui NY, Kawasaki A, Wu JM. Long-term outcomes after stress urinary incontinence surgery. Obstet Gynecol. 2012;120(1):83–90.PubMedCrossRefGoogle Scholar
  50. 50.
    Fialkow M, Symons RG, Flum D. Reoperation for urinary incontinence. Am J Obstet Gynecol. 2008;199:546.e1–8.CrossRefGoogle Scholar
  51. 51.
    Zimmern PE, Gormley EA, Stoddard AM, et al. Management of recurrent stress urinary incontinence after burch and sling procedures. Neurourol Urodyn. 2016;35(3):344–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Eandi JA, Tanaka ST, Hellenthal NJ, et al. Self-reported urinary continence outcomes for repeat midurethral synthetic sling placement. Int Braz J Urol. 2008;34:336–44.PubMedCrossRefGoogle Scholar
  53. 53.
    Pradhan A, Jain P, Latthe PM. Effectiveness of midurethral slings in recurrent stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2012;23(7):831–41.PubMedCrossRefGoogle Scholar
  54. 54.
    Parden AM, Gleason JL, Jauk V, Garner R, Ballard A, Richter HE. Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures. Obstet Gynecol. 2013;121(2 Pt 1):273–8.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Hashim H, Terry T. Management of recurrent stress urinary incontinence and urinary retention following midurethral sling insertion in women. Ann R Coll Surg Engl. 2012;94(7):517–22.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Cerniauskiene A, Barisiene M, Jankevicius F, Januska G. Treatment of recurrent stress urinary incontinence in women: comparison of treatment results for different surgical techniques. Wideochir Inne Tech Maloinwazyjne. 2014;9(2):239–45.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Sivaslioglu AA, Unlubilgin E, Keskin HL, et al. The management of recurrent cases after the Burch colposuspension: 7 years experience. Arch Gynecol Obstet. 2011;283:787–90.PubMedCrossRefGoogle Scholar
  58. 58.
    Gaddi A, Guaderrama N, Bassiouni N, Bebchuk J, Whitcomb EL. Repeat midurethral sling compared with urethral bulking for recurrent stress urinary incontinence. Obstet Gynecol. 2014;123(6):1207–12.PubMedCrossRefGoogle Scholar
  59. 59.
    Aref-Adib M, Lamb BW, Lee HB, et al. Stem cell therapy for stress urinary incontinence: a systematic review in human subjects. Arch Gynecol Obstet. 2013;288(6):1213–21.PubMedCrossRefGoogle Scholar
  60. 60.
    Biardeau X, Aharony S, AUS Consensus Group, Campeau L, Corcos J. Overview of the 2015 ICS consensus conference. Neurourol Urodyn. 2016;35(4):437–43.PubMedCrossRefGoogle Scholar
  61. 61.
    Lucas MG, Bosch RJL, Burkhard FC, et al. European Association of Urology guidelines on assessment and nonsurgical management of urinary incontinence. Actas Urol Esp. 2013;37(4):199–213.PubMedCrossRefGoogle Scholar
  62. 62.
    Fritel X, Fauconnier A, Bader G, et al. Diagnosis and management of adult female stress urinary incontinence: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol. 2010;151(1):14–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Hermieu J-F, Conquy S, Leriche B, et al. Synthèse des recommand-tion pour le traitement de l’incontinence urinaire feminine non neurologique. Prog Urol. 2010;20:S94–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Chapple CR, Cruz F, Deffieux X, et al. Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. Eur Urol. 2017;72(3):424–31.Google Scholar
  65. 65.
    Fusco F, Abdel-Fattah M, Chapple CR, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol. 2017;72(4):567–91.Google Scholar
  66. 66.
    Nadeau G, Herschorn S. Management of recurrent stress incontinence following a sling. Curr Urol Rep. 2014;15(8):427.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Giampiero Capobianco
    • 1
    Email author
  • Pier Luigi Cherchi
    • 1
  • Salvatore Dessole
    • 1
  1. 1.Department of Medical, Surgical and Experimental SciencesUniversity of Sassari, Gynecologic and Obstetric ClinicSassariItaly

Personalised recommendations